Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjoncology logo
VJHemOnc
Logo
  • Home (current)
  • Diseases
    CLL
    Multiple Myeloma
    Myeloproliferative Neoplasms
    ALL
    AML
    Lymphoma
    View all Diseases
  • Topics
    Transplantation
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    View all Topics
  • Conferences
    ASH
    2019
    MPN Advances Day
    2019
    iwCAR-T
    2019
    COSTEM
    2019
    ESMO
    2019
    iwCLL
    2019
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

EHA 2017

5:27
Two is better than one: drug synergy in relapsed/refractory NHL
Paul A. Hamlin
2:34
Key topics on AML at EHA 2017
Oliver Ottmann
0:52
T-cell therapy: successes and unmet needs
David Maloney
2:31
The ideal sequence: treating patients with CLL
Florence Cymbalista
2:00
What are the non-drug-related aspects of patient care?
Claire Harrison
2:19
The potential of momelotinib against myeloproliferative malignancies
Claire Harrison
6:07
A CRISPR approach to hematological research
Sven Lundberg
4:34
What is the focus of EHA?
Shai Izraeli
2:04
Venetoclax and ibrutinib: the future for treating WM
Steven Treon
0:53
NEOD001 in amyloidosis
Morie Gertz
4:16
Can a epoetin biosimilar be used to treat chemotherapy-induced anemia?
Paul Cornes
4:56
A question of age: how should elderly DLBCL patients be treated?
Marek Trněný
2:24
Future challenges facing hematological malignancies
Robin Foà
3:13
EHA 2017: keeping in touch with the world
Robin Foà
3:00
The joint symposium run by EHA and ESH
Steve Johnson
3:39
Novel agents for myeloma related bone disease
Evangelos Terpos
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Next
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Continue

Please enter your details if you would like to receive the latest hemonc news and updates

Sign up
Disease Channels
  • CLL
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • ALL
  • AML
  • Lymphoma
  • View all
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up
mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJHemOnc logo
The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy